Research Method, Conduct, and Reporting Considerations for Improving the Quality of Non-Hypothesis-Evaluating Treatment Effectiveness Analyses Using Real-World Data: An ISPOR Special Interest Group Report.

Saved in:
Bibliographic Details
Title: Research Method, Conduct, and Reporting Considerations for Improving the Quality of Non-Hypothesis-Evaluating Treatment Effectiveness Analyses Using Real-World Data: An ISPOR Special Interest Group Report.
Authors: Barrette E; Medtronic Inc, Washington DC, USA., Crown WH; Brandeis University, Waltham, MA, USA. Electronic address: wcrown@brandeis.edu., Hanisch M; Merck and Co, Inc, Rahway, NJ, USA., Alfonso-Cristancho R; GSK, Collegeville, PA, USA., Sheth S; Novo Nordisk, Plainsboro, NJ, USA., Gautier SCZ; Rutgers, The State University of New Jersey, New Brunswick, NJ, USA., Surinach A; Genesis Research Group, Real World Evidence and Synthesis Solutions, Hoboken, NJ, USA., Cziraky M; Carelon Research, Wilmington, DE, USA., Morrow JD; Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA., Buikema AR; Value and Evidence Consulting, Optum, Eden Prairie, MN, USA.
Source: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2025 Jul; Vol. 28 (7), pp. 979-987. Date of Electronic Publication: 2025 Apr 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1524-4733
DOI:10.1016/j.jval.2025.02.017